Tesamorelin
The only peptide FDA-approved to target visceral fat.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) and the only peptide with FDA approval specifically for reducing visceral adipose tissue — the dangerous deep abdominal fat that accumulates with age, hormonal decline, and metabolic dysfunction.
The Science
How It Works
Tesamorelin binds to GHRH receptors in the pituitary gland, stimulating a strong, sustained release of growth hormone. Elevated GH levels then directly target visceral fat through lipolysis — breaking down stored triglycerides in adipose tissue. Unlike general fat loss approaches, Tesamorelin has a preferential effect on visceral fat specifically.
What to Expect
Key Benefits
Targeted Visceral Fat Reduction
Clinical trials show an average 15–20% reduction in visceral fat with Tesamorelin — the stubborn midsection fat that diet and exercise alone rarely touch.
Preserved Lean Muscle Mass
Unlike caloric restriction, Tesamorelin reduces fat while preserving or improving lean muscle — improving body composition, not just weight.
Improved Metabolic Markers
Reduces triglycerides, improves insulin sensitivity, and lowers inflammatory markers associated with metabolic syndrome.
Cardiovascular Risk Reduction
Visceral fat is a primary driver of cardiovascular disease. Reducing it directly lowers cardiovascular risk.
Improved Physical Appearance
Men consistently report a flatter, more defined midsection — one of the most visible and motivating results of the protocol.
Find out if Tesamorelin is right for you.
A free 20-minute call with our physician team. No commitment required.
Who It's For
Men with significant visceral fat accumulation, metabolic syndrome, or those who have struggled to lose abdominal fat despite diet and exercise. Particularly effective when combined with TRT and other hormone optimization protocols.
Administration
Daily subcutaneous injection, typically in the abdominal area. Clinical protocols run 26–52 weeks for maximum visceral fat reduction.
Safety Profile
FDA-approved with a well-established safety profile. Most common side effects are mild injection site reactions. Contraindicated in active malignancy.
Ready to Start a Tesamorelin Protocol?
Book a free consultation with our medical team. We'll review your labs and determine if Tesamorelin is right for your goals.